Examkin

Soru

Zorluk: Çok zorPharmacologic Interventions

A 72-year-old man with a history of severe ischemic cardiomyopathy is brought to the emergency department with progressive dyspnea, orthopnea, and worsening confusion over the past 24 hours. Vital signs show a temperature of 37.1°C (98.8°F), blood pressure of 74/50 mm Hg, heart rate of 118/min, and respiratory rate of 28/min. Physical examination reveals cool, mottled extremities, significant jugular venous distention, and coarse bilateral crackles extending to the mid-lung fields. Urine output since arrival has been minimal. A bedside echocardiogram demonstrates a left ventricular ejection fraction of 20% with severe global hypokinesis and a dilated, non-collapsible inferior vena cava. Arrange the following pharmacologic interventions in the most appropriate sequential order for the management of this patient, starting with the most immediate stabilizing action.

  1. 1Initiation of an intravenous norepinephrine infusion
  2. 2Initiation of an intravenous dobutamine infusion
  3. 3Administration of an intravenous furosemide bolus
  4. 4Initiation of low-dose oral bisoprolol

Cevap

The correct sequence is: Intravenous norepinephrine, followed by intravenous dobutamine, followed by intravenous furosemide, and finally oral bisoprolol once the patient is completely stabilized.
The most critical initial step in managing cardiogenic shock with severe hypotension (systolic blood pressure < 80 mm Hg) and end-organ hypoperfusion is to restore adequate perfusion pressure using a vasopressor, with norepinephrine being the preferred agent. Once a safe mean arterial pressure is established, an inotrope such as dobutamine is added to improve myocardial contractility; administering dobutamine prior to a vasopressor is contraindicated due to its beta-2 mediated vasodilatory effects which would acutely worsen hypotension. Following hemodynamic stabilization and restoration of renal perfusion, intravenous loop diuretics (furosemide) are administered to treat pulmonary congestion. Finally, oral beta-blockers (bisoprolol) are strictly avoided during the acute decompensation phase and are only initiated once the patient is completely hemodynamically stable, euvolemic, and weaned from vasoactive support.

Adım Adım Çözüm

1
Identify the primary physiologic derangement.
The patient is in profound cardiogenic shock with severe hypotension (74/50 mm Hg) and end-organ hypoperfusion.
Establishing the severity of shock dictates the immediate need for perfusion restoration over decongestion.
2
Determine the first-line pharmacologic intervention.
Initiation of intravenous norepinephrine.
In cardiogenic shock with a systolic blood pressure < 80 mm Hg, an alpha-1 agonist is necessary to increase systemic vascular resistance and restore coronary and cerebral perfusion pressure before other therapies can be effective.
3
Determine the next step to address the underlying cardiac dysfunction.
Initiation of intravenous dobutamine.
Once a safe blood pressure is achieved, an inotrope is added to improve left ventricular contractility and cardiac output. It cannot be given first due to its vasodilatory properties.
4
Address the patient's volume status.
Administration of intravenous furosemide.
Pulmonary congestion must be relieved, but loop diuretics require adequate renal perfusion to function effectively, making this a subsequent step after hemodynamic stabilization.
5
Plan for long-term medical management.
Initiation of oral bisoprolol.
Guideline-directed medical therapy for heart failure is initiated only after acute stabilization, as starting it during active shock would cause cardiovascular collapse.

Anahtar Kavram

In cardiogenic shock with profound hypotension (SBP < 80 mm Hg), perfusion pressure must be restored with a vasopressor (norepinephrine) before initiating inotropes (which can vasodilate) or diuretics (which require renal perfusion).
Tahmini Süre:2m 0s
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru